Association between circulating ANGPTL4 levels and laboratory tests relevant to impaired glycometabolism, hepatic impairment or inflammation (n = 800).

<p>A generalized linear model was used. To evaluate HbA_1C or glucose, each covariate was adjusted by all variables listed in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0193731#pone.0193731.t003" target="_blank">Table 3</a>, minus the impaired glyometabolism category. To evaluate AST, ALT, or GGT, each covariate was adjusted by all variables listed in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0193731#pone.0193731.t003" target="_blank">Table 3</a>, minus the hepatic impairment category. To evaluate hs-CRP, each covariate was adjusted by all variables listed in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0193731#pone.0193731.t003" target="_blank">Table 3</a>, minus inflammation. β, regression coefficient; 95% CI, 95% confidence interval; HbA_1C, hemoglobin A_1C; AST, aspartate transaminase; ALT, alanine transaminase; GGT, Gamma-glutamyltransferase; and hs-CRP, high sensitivity C reactive protein.